当前位置: X-MOL 学术Crit. Care › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Outcomes of hospitalized hematologic oncology patients receiving rapid response system activation for acute deterioration: another time, another way
Critical Care ( IF 15.1 ) Pub Date : 2019-12-01 , DOI: 10.1186/s13054-019-2714-0
Belén Civantos 1 , José Manuel Añón 1, 2 , Santiago Yus 1 , María José Asensio 1 , Abelardo García-de-Lorenzo 1
Affiliation  

Dear Editor, We have read the recent article written by Gershkovich et al. [1]. In this paper, the authors sought to examine the outcomes of hospitalized hematologic oncology patients requiring rapid response system (RRS) activation after clinical deterioration and to identify the factors that are independently associated with in-hospital mortality. The authors concluded that hematologic oncology patients who are admitted to the hospital and suffer an acute deterioration experience high rates of ICU admission and in-hospital mortality. In recent years, there has been an increase in the number of hematologic oncology patients admitted to ICUs. Currently, this condition is no longer a criterion to dismiss admission to the ICU [2]. Due to the continuous increase in the number of these patients and the complexity of their disease, we developed in 2012 a new strategy to optimize the management of this type of patients. We considered that RRS did not reflect accurately the severity of their condition. To date, the role of these alert systems is not yet clearly established [1]. Our strategy is based on daily multidisciplinary ward rounds with hematologists and intensivists in order to identify the high-risk patients and to admit them early to the ICU. The association between early versus late ICU admission and improved survival in hematologic oncology patients has been previously established [3]. Our data before (2000–2011) and after (2012–2016) implementation shows the following:

中文翻译:

因急性恶化而接受快速反应系统激活的住院血液肿瘤患者的结果:另一个时间,另一种方式

亲爱的编辑,我们已经阅读了 Gershkovich 等人最近撰写的文章。[1]。在本文中,作者试图检查在临床恶化后需要快速反应系统 (RRS) 激活的住院血液肿瘤患者的结果,并确定与院内死亡率独立相关的因素。作者得出的结论是,入院并出现急性恶化的血液肿瘤患者入住 ICU 和院内死亡率很高。近年来,入住ICU的血液肿瘤患者数量有所增加。目前,这种情况不再是拒绝入住 ICU 的标准 [2]。由于这些患者的数量不断增加,疾病的复杂性,我们在 2012 年制定了优化此类患者管理的新策略。我们认为 RRS 没有准确反映他们病情的严重程度。迄今为止,这些警报系统的作用尚未明确[1]。我们的策略基于每天与血液学家和重症监护医师进行多学科查房,以识别高危患者并尽早将他们送入 ICU。先前已确定早期与晚期入住 ICU 与血液肿瘤患者生存率提高之间的关联 [3]。我们在实施之前(2000-2011)和之后(2012-2016)的数据显示如下:这些警报系统的作用尚未明确[1]。我们的策略基于每天与血液学家和重症监护医师进行多学科查房,以识别高危患者并尽早将他们送入 ICU。先前已确定早期与晚期入住 ICU 与血液肿瘤患者生存率提高之间的关联 [3]。我们在实施之前(2000-2011)和之后(2012-2016)的数据显示如下:这些警报系统的作用尚未明确[1]。我们的策略基于每天与血液学家和重症监护医生进行多学科查房,以识别高危患者并尽早将他们送入 ICU。先前已确定早期与晚期入住 ICU 与血液肿瘤患者生存率提高之间的关联 [3]。我们在实施之前(2000-2011)和之后(2012-2016)的数据显示如下:
更新日期:2019-12-01
down
wechat
bug